The development and application of nanotechnology to biology and medicine is a rapidly evolving research area. Our overall laboratory goal is to develop new core technologies based on the unique properties on nanomaterials to significantly impact the future of medicine. With support from DOD and NIH, lab co-directors Todd Giorgio and Rick Haselton lead a team that is developing and testing novel nanoparticle designs for a variety of applications. Some of these are the rapid detection of virus in a clinical sample, the early stage detection of cancerous cells, the identification of atherosclerotic plaques and the rapid detection of hospital pathogens. Current projects focus on developing quantum dots, gold or iron oxide nanoparticles to efficiently home to the target of interest, to actively respond to environmental cues and to effectively report the target’s location and state.
|Dec 2012. Prof. Todd Giorgio received $1,500,000 in funding from the DOD Peer-Reviewed Medical Research Program and the Breast Cancer Research Program for the next three years! These collaborative awards support several postdoctoral associates and graduate students. Congratulations to all of our collaborators and co-writers for contributing to the successful applications!|
|Aug 2012. Giorgio Lab's Shann Yu will be awarded a 2012 Research & Design Award from the Biomedical Engineering Society at the Annual Meeting in Atlanta, GA in October. This award is given to selected abstracts submitted for presentations at the annual meeting. Congratulations also to the co-authors who contributed to this work! Click here for the BMES announcement!|
|June 2012. Giorgio Lab's Hongmei Li was awarded a 2012 Outstanding Consumer & Diversified Products Best Paper Award from the Controlled Release Society, awarded to a selected abstract submitted for a presentation at the annual meeting in Quebec City, Canada. Click here for the abstract! Congratulations also to the co-authors of this work!|